NASDAQ:SYNO - Synovis Life Technologies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Synovis Life Technologies, Inc. (Synovis) is a medical device company. The Company develops, manufactures and markets biological and mechanical products used by several surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. Its products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools. The Company operates in three segments: the surgical business, the microsurgical business, and the Ortho & Wound business. Its surgical business develops, manufactures, markets, and sells implantable biomaterial products and surgical tools. Its surgical business products include Peri-Strips, Tissue Guard, Veritas, and Surgical Tools. The Company's microsurgical business develops, manufactures, markets, and sells devices serving the niche market of microsurgery. In February 2012, Baxter International Inc. acquired Synovis.

Receive SYNO News and Ratings via Email

Sign-up to receive the latest news and ratings for SYNO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:SYNO
CUSIPN/A
WebN/A
Phone+1-651-7967300

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Synovis Life Technologies (NASDAQ:SYNO) Frequently Asked Questions

What is Synovis Life Technologies' stock symbol?

Synovis Life Technologies trades on the NASDAQ under the ticker symbol "SYNO."

Has Synovis Life Technologies been receiving favorable news coverage?

Media coverage about SYNO stock has trended somewhat positive on Wednesday, Accern reports. Accern rates the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Synovis Life Technologies earned a coverage optimism score of 0.25 on Accern's scale. They also assigned headlines about the medical device company an impact score of 47.13 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Synovis Life Technologies?

Shares of SYNO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Synovis Life Technologies?

Synovis Life Technologies' mailing address is 2575 University Ave W, SAINT PAUL, MN 55114-1024, United States. The medical device company can be reached via phone at +1-651-7967300.


MarketBeat Community Rating for Synovis Life Technologies (SYNO)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  66 (Vote Underperform)
Total Votes:  114
MarketBeat's community ratings are surveys of what our community members think about Synovis Life Technologies and other stocks. Vote "Outperform" if you believe SYNO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SYNO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.